What is the community benefit from the National Emerging Infectious Diseases Laboratories?
Research at the NEIDL is important to public health, locally and throughout the world. It will benefit the community through development of new treatments, diagnostics and preventive vaccines against emerging and reemerging infectious diseases. The NEIDL had a significant local economic and community impact during the construction phase. More than 1,300 construction jobs were created. An anticipated 660 permanent jobs — at all levels including: environmental services, lab technicians, scientists and administrative staff– will be created as part of the facility’s operation. The NEIDL will contribute $1.9 million in job training and housing linkage payments to the City of Boston. In addition, BUMC and Boston University will continue to make Payments in Lieu of Taxes (PILOT) to the City of Boston. Currently, BUMC makes PILOT payments in excess of $300,000 per year and Boston University makes annual PILOT payments of $3.2 million and tax payments of $3 million.
